2026 ICD-10-CM Diagnosis Code E74.02Pompe disease
ICD-10-CM Codes›E00–E89›E70-E88›E74
- Billable — Valid for Submission
- Chronic Condition
E74.02 is a billable ICD-10-CM diagnosis code for pompe disease. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). Coders also document this condition as cardiac glycogenosis. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified nutritional and metabolic disorders.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Cardiac glycogenosis
- Deficiency of alpha-glucosidase
- Deficiency of glucan 1,4-alpha-glucosidase
- Fatal congenital nonlysosomal heart glycogenosis
- Glycogen storage disease due to acid maltase deficiency
- Glycogen storage disease due to acid maltase deficiency, infantile onset
- Glycogen storage disease due to acid maltase deficiency, late-onset
- Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency
- Infiltrative cardiomyopathy
- Lysosomal storage disease
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Cardiac glycogenosis
- Type II glycogen storage disease
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Cardiomegalia glycogenica diffusa - E74.02
- Cardiomegaly - See Also: Hypertrophy, cardiac;
- glycogen - E74.02
- Cardiomyopathy (familial) (idiopathic) - I42.9
- due to
- cardiac glycogenosis - E74.02
- glycogen storage - E74.02
- lysosomal alpha-1, 4 glucosidase - E74.02
- Disease, diseased - See Also: Syndrome;
- heart - E74.02
- lysosomal - E74.02
- with acid maltase deficiency - E74.02
- myocardium - E74.02
- Pompe's - E74.02
- type II - E74.02
- heart (organic) - I51.9
- glycogen storage - E74.02
- Pompe's (glycogenosis II) - E74.02
- Glycogenosis (diffuse) (generalized) - See Also: Disease, glycogen storage;
- cardiac - E74.02
- cardiac
- glycogenic - E74.02
- glycogenic - E74.02
- glycogenic - E74.02
- Myocardiopathy (congestive) (constrictive) (familial) (hypertrophic nonobstructive) (idiopathic) (infiltrative) (obstructive) (primary) (restrictive) (sporadic) - See Also: Cardiomyopathy; - I42.9
- glycogen storage - E74.02
- cardiac glycogenosis - E74.02
- Pompe's disease (glycogen storage) - E74.02
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Cardiomegalia glycogenica diffusa
- Cardiomegaly
- glycogen
- Cardiomyopathy(familial) (idiopathic)
- due to
- cardiac glycogenosis
- Cardiomyopathy(familial) (idiopathic)
- glycogen storage
- Deficiency, deficient
- lysosomal alpha-1, 4 glucosidase
- Disease, diseased
- glycogen storage
- heart
- Disease, diseased
- glycogen storage
- lysosomal
- Disease, diseased
- glycogen storage
- lysosomal
- with acid maltase deficiency
- Disease, diseased
- glycogen storage
- myocardium
- Disease, diseased
- glycogen storage
- Pompe's
- Disease, diseased
- glycogen storage
- type II
- Disease, diseased
- heart (organic)
- glycogen storage
- Disease, diseased
- Pompe's (glycogenosis II)
- Glycogenosis(diffuse) (generalized)
- cardiac
- Infiltrate, infiltration
- cardiac
- glycogenic
- Infiltrate, infiltration
- heart, cardiac
- glycogenic
- Infiltrate, infiltration
- myocardium, myocardial
- glycogenic
- Myocardiopathy(congestive) (constrictive) (familial) (hypertrophic nonobstructive) (idiopathic) (infiltrative) (obstructive) (primary) (restrictive) (sporadic)
- glycogen storage
- Myocardiopathy(congestive) (constrictive) (familial) (hypertrophic nonobstructive) (idiopathic) (infiltrative) (obstructive) (primary) (restrictive) (sporadic)
- in (due to)
- cardiac glycogenosis
- Pompe's disease(glycogen storage)
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Myocardial Degeneration
degeneration of myocardial tissue.
Patient EducationClinical
Carbohydrate Metabolism Disorders
Metabolism is the process your body uses to make energy from the food you eat. Food is made up of proteins, carbohydrates, and fats. Chemicals in your digestive system (enzymes) break the food parts down into sugars and acids, your body's fuel. Your body can use this fuel right away, or it can store the energy in your body tissues.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert E74.02 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About E74.02Overview
Is E74.02 (Glycogen storage disease) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report pompe disease on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What is the ICD-9 equivalent of E74.02?
Under the General Equivalence Mappings, pompe disease converts to ICD-9-CM 271.0 (glycogenosis). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
